Regulator OKs P3 trial for Eisai’s Alzheimer treatment – Korea Biomedical Review

June 25, 2019 by  
Filed under Alzheimers News

Sponsored By

Regulator OKs P3 trial for Eisai’s Alzheimer treatment  Korea Biomedical Review

The Ministry of Food and Drug Safety has approved the phase 3 clinical trial of Eisai’s BAN2401, an Alzheimer’s disease treatment candidate, applied by Linical …

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*